Goldman Sachs’s Imperva, Inc. IMPV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,602,636
Closed -$89.3M 5665
2018
Q4
$89.3M Buy
1,602,636
+594,915
+59% +$32.3M 0.03% 674
2018
Q3
$46.8M Buy
1,007,721
+91,581
+10% +$4.43M 0.01% 1272
2018
Q2
$44.2M Buy
916,140
+12,527
+1% +$599K 0.01% 1299
2018
Q1
$39.1M Buy
903,613
+645,816
+251% +$29M 0.01% 1357
2017
Q4
$10.2M Sell
257,797
-18,730
-7% -$781K ﹤0.01% 2445
2017
Q3
$12M Sell
276,527
-434,805
-61% -$19.8M ﹤0.01% 2420
2017
Q2
$34M Buy
711,332
+34,923
+5% +$1.63M 0.01% 1529
2017
Q1
$27.8M Buy
676,409
+51,983
+8% +$2.17M 0.01% 1657
2016
Q4
$24M Buy
624,426
+432,922
+226% +$17.6M 0.01% 1837
2016
Q3
$10.3M Buy
191,504
+34,230
+22% +$1.59M ﹤0.01% 2425
2016
Q2
$6.76M Buy
157,274
+122,639
+354% +$5.15M ﹤0.01% 2622
2016
Q1
$1.75M Sell
34,635
-78,254
-69% -$3.76M ﹤0.01% 3605
2015
Q4
$7.15M Buy
112,889
+90,288
+399% +$6.15M ﹤0.01% 2527
2015
Q3
$1.48M Sell
22,601
-24,062
-52% -$1.6M ﹤0.01% 4093
2015
Q2
$3.16M Buy
46,663
+4,573
+11% +$252K ﹤0.01% 3384
2015
Q1
$1.8M Buy
42,090
+19,090
+83% +$849K ﹤0.01% 3900
2014
Q4
$1.14M Buy
23,000
+2,325
+11% +$93.1K ﹤0.01% 4422
2014
Q3
$594K Buy
20,675
+1,441
+7% +$39.1K ﹤0.01% 5117
2014
Q2
$504K Buy
19,234
+7,927
+70% +$205K ﹤0.01% 5311
2014
Q1
$630K Sell
11,307
-5,323
-32% -$306K ﹤0.01% 5067
2013
Q4
$801K Sell
16,630
-6,867
-29% -$289K ﹤0.01% 4930
2013
Q3
$987K Buy
23,497
+19,276
+457% +$918K ﹤0.01% 4599
2013
Q2
$190K Buy
+4,221
New +$165K ﹤0.01% 5624

Goldman Sachs's IMPV Position: Q1 2019 in Review

Goldman Sachs sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 1,602,636 shares — an estimated $89.3M sold.

Goldman Sachs first reported a position in IMPV in Q2 2013 and held it in 23 quarters. The position peaked at $89.3M in Q4 2018. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.

  • Goldman Sachs reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
  • Goldman Sachs sold 1,602,636 Imperva, Inc. shares in Q1 2019, an estimated $89.3M.
  • Goldman Sachs first reported a position in Imperva, Inc. in Q2 2013 and held it in 23 quarters.
  • Goldman Sachs's Imperva, Inc. position peaked at $89.3M in Q4 2018.
  • 0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.

Based on Goldman Sachs's 13F filing for Q1 2019, filed 15 May 2019.